Avalo Therapeutics (AVTX) EBIT Margin (QoQ) (2016 - 2024)
Avalo Therapeutics (AVTX) EBIT Margin (QoQ) (2016 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Avalo Therapeutics |
295.77 Mn |
295.77 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-176,775.00 |
| Dec 31, 2023 |
24,783.00 |
| Sep 30, 2023 |
-47,701.00 |
| Jun 30, 2023 |
73,897.00 |
| Mar 31, 2023 |
-86,267.00 |
| Dec 31, 2022 |
-101,567.00 |
| Sep 30, 2022 |
117,241.00 |
| Jun 30, 2022 |
63,273.00 |
| Mar 31, 2022 |
642,453.00 |
| Dec 31, 2021 |
-698,280.00 |
| Sep 30, 2021 |
-70,893.00 |
| Jun 30, 2021 |
595,456.00 |
| Mar 31, 2021 |
-537,367.00 |
| Dec 31, 2020 |
10,360.00 |
| Sep 30, 2020 |
-31,202.00 |
| Jun 30, 2020 |
25,760.00 |
| Mar 31, 2020 |
-15,531.00 |
| Dec 31, 2019 |
-85,532.00 |
| Sep 30, 2019 |
5,306.00 |
| Jun 30, 2019 |
1,120.00 |
